Cargando…

Topical Triamcinolone Acetonide-Loaded Liposome Formulation Used as an Adjuvant to Intravitreal Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration

Novel strategies have been developed to reduce or avoid intravitreal injections (IVTs) of the antiangiogenic (ranibizumab (RBZ)) and anti-inflammatory (triamcinolone acetonide (TA)) agents used to treat vitreoretinal diseases. One of the strategies includes liposomes. This study evaluated the safety...

Descripción completa

Detalles Bibliográficos
Autores principales:	Navarro-Partida, Jose, Altamirano-Vallejo, Juan Carlos, Aceves Franco, Luis Abraham, Gonzalez-Cortes, Jesús, Hernandez-Da Mota, Sergio, García-Aguirre, Jose Gerardo, Azuara-Galindo, Carlos David, Castro-Castaneda, Carlos Rodrigo, Armendariz-Borunda, Juan, Santos, Arturo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471461/ https://www.ncbi.nlm.nih.gov/pubmed/34575567 http://dx.doi.org/10.3390/pharmaceutics13091491

Ejemplares similares

Safety and Tolerability of Topical Ophthalmic Triamcinolone Acetonide-Loaded Liposomes Formulation and Evaluation of Its Biologic Activity in Patients with Diabetic Macular Edema
por: Navarro-Partida, Jose, et al.
Publicado: (2021)

Novel Triamcinolone Acetonide-Loaded Liposomes Topical Formulation for the Treatment of Cystoid Macular Edema After Cataract Surgery: A Pilot Study
por: Gonzalez-De la Rosa, Alejandro, et al.
Publicado: (2019)

Novel Triamcinolone Acetonide-Loaded Liposomal Topical Formulation Improves Contrast Sensitivity Outcome After Femtosecond Laser-Assisted Cataract Surgery
por: Gonzalez-De la Rosa, Alejandro, et al.
Publicado: (2019)

Intravitreal Ranibizumab Versus Intravitreal Ranibizumab Combined with Posterior Subtenon Triamcinolone Acetonide in Diabetic Macular Edema
por: Karatas, Gamze, et al.
Publicado: (2021)

Photodynamic monotherapy or combination treatment with intravitreal triamcinolone acetonide, bevacizumab or ranibizumab for choroidal neovascularization associated with pathological myopia
por: Rishi, Pukhraj, et al.
Publicado: (2011)

Combined intravitreal ranibizumab and posterior subtenon triamcinolone acetonide injections for patients with diabetic macular edema refractory to intravitreal ranibizumab monotherapy
por: Chiu, Chiung-Yi, et al.
Publicado: (2021)

Patients treated with intravitreal triamcinolone acetonide
por: Gallenga, Pier E, et al.
Publicado: (2008)

Intravitreal Bevacizumab versus Combined Bevacizumab and Triamcinolone Acetonide for Neovascular Age-Related Macular Degeneration
por: Riazi-Esfahani, Mohammad, et al.
Publicado: (2008)

Efficacy of Intravitreal Injection of Filtered Modified Low-Dose Triamcinolone Acetonide and Ranibizumab on Pseudophakic Cystoid Macular Edema
por: Tariq, Farheen, et al.
Publicado: (2022)

The Evolution of Triamcinolone Acetonide Therapeutic Use in Retinal Diseases: From Off-Label Intravitreal Injection to Advanced Nano-Drug Delivery Systems
por: Aceves-Franco, Luis Abraham, et al.
Publicado: (2023)

Intraocular Pressure Following Intravitreal Injection of Triamcinolone Acetonide
por: Ansari, Ejaz A, et al.
Publicado: (2008)

Modified Microneedle for Suprachoroidal Injection of Triamcinolone Acetonide Combined with Intravitreal Injection of Ranibizumab in Branch Retinal Vein Occlusion Patients
por: Nawar, Amin E
Publicado: (2022)

Sterile endophthalmitis following intravitreal triamcinolone acetonide in July 2010
por: Kim, Moosang, et al.
Publicado: (2015)

Effect of photodynamic therapy (PDT), posterior subtenon injection of triamcinolone acetonide with PDT, and intravitreal injection of ranibizumab with PDT for retinal angiomatous proliferation
por: Nakano, Saya, et al.
Publicado: (2012)

Efficacy of Intravitreal Triamcinolone Acetonide for Eyes with Postvitrectomy Diabetic Vitreous Hemorrhage
por: Lee, Sun Young, et al.
Publicado: (2007)

Pharmacokinetics and retinal toxicity of various doses of intravitreal triamcinolone acetonide in rabbits
por: Ye, You-Fan, et al.
Publicado: (2014)

Intravitreal Triamcinolone Acetonide in Von Hippel–Lindau Patient with Novel Mutation
por: Bunajem, Maryam, et al.
Publicado: (2020)

Suprachoroidal versus Intravitreal Triamcinolone Acetonide for the Treatment of Diabetic Macular Edema
por: Zakaria, Yousra Gamal, et al.
Publicado: (2022)

Comparison between intravitreal ranibizumab injection and posterior subtenon triamcinolone acetonide injection at time of cataract surgery for prevention of progression of diabetic macular edema
por: Khalil, Mahmoud Mohammed Ahmed Ali, et al.
Publicado: (2022)

Single intravitreal ranibizumab for myopic choroidal neovascularization
por: Nor-Masniwati, Saidin, et al.
Publicado: (2011)

Triamcinolone acetonide acetate
por: Lu, Xiao, et al.
Publicado: (2011)

Intravitreal vs. subtenon triamcinolone acetonide for the treatment of diabetic cystoid macular edema
por: Cellini, Mauro, et al.
Publicado: (2008)

Use of intravitreal injection of triamcinolone acetonide in the treatment of age-related macular degeneration
por: Gopal, Lekha, et al.
Publicado: (2007)

Dose Dependent Effects of Intravitreal Triamcinolone Acetonide on Diffuse Diabetic Macular Edema
por: Bae, Joon Sung, et al.
Publicado: (2009)

Intravitreal versus Posterior Subtenon Injection of Triamcinolone Acetonide for Diabetic Macular Edema
por: Choi, Young Jae, et al.
Publicado: (2006)

Retinal Capillary Hemangioma Treated with Verteporfin Photodynamic Therapy and Intravitreal Triamcinolone Acetonide
por: Suh, Shin Cho, et al.
Publicado: (2007)

Behavior of Intraocular Pressure After Intravitreal Injection of Triamcinolone Acetonide Among Egyptians
por: Ghoneim, Ehab M., et al.
Publicado: (2013)

Distribution of Triamcinolone Acetonide after Intravitreal Injection into Silicone Oil-Filled Eye
por: Da, Ma, et al.
Publicado: (2016)

Diabetic macular edema: Safe and effective treatment with intravitreal triamcinolone acetonide (Taioftal)
por: Sorrentino, Francesco Saverio, et al.
Publicado: (2021)

Intravitreal Triamcinolone Acetonide Presents a Diagnostic Challenge on Noncontrast Computed Tomography
por: Ahmad, Kinza T., et al.
Publicado: (2022)

Retinal Microvascular Changes after Intravitreal Triamcinolone Acetonide in Diabetic Macular Edema
por: Kato, Fusae, et al.
Publicado: (2023)

Triamcinolone Acetonide as an Adjunct to Bevacizumab for Prevention of Corneal Neovascularization in a Rat Model
por: Mehrjardi, Hadi Z., et al.
Publicado: (2014)

Clinical Efficacy of Intravitreal Ranibizumab in Early and Mid-Idiopathic Choroidal Neovascularization
por: Fan, Chuanfeng, et al.
Publicado: (2014)

Intravitreal bevacizumab alone or combined with triamcinolone acetonide as the primary treatment for diabetic macular edema
por: Marey, Hatem M, et al.
Publicado: (2011)

Intravitreal Triamcinolone Acetonide Injection at the Time of Pars Plana Vitrectomy for Retained Lens Material
por: Kim, Na Rae, et al.
Publicado: (2009)

The Effect of an Intravitreal Triamcinolone Acetonide Injection for Acute Nonarteritic Anterior Ischemic Optic Neuropathy
por: Sohn, Byung Jae, et al.
Publicado: (2009)

Intravitreal triamcinolone acetonide: Pattern of secondary intraocular pressure rise and possible risk factors
por: Bashshur, Ziad F, et al.
Publicado: (2008)

Response to correspondence from Gallenga and Lobefalo Re: Patients treated with intravitreal triamcinolone acetonide
por: Kocabora, M Selim
Publicado: (2008)

Simulating Dissolution of Intravitreal Triamcinolone Acetonide Suspensions in an Anatomically Accurate Rabbit Eye Model
por: Missel, Paul J., et al.
Publicado: (2010)

Intravitreal Triamcinolone Acetonide for Macular Edema in HLA-B27 Negative Ankylosing Spondylitis
por: Moschos, M.M., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_b51oebiqls9ao1nj0v0efgc8it